Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels

Cav2.2 channels are key regulators of presynaptic Ca<sup>2+</sup> influx and their dysfunction and/or aberrant regulation has been implicated in many disease states; however, the nature of their involvement in Alzheimer’s disease (AD) is less clear. In this short communication, we show t...

Full description

Bibliographic Details
Main Authors: Eleni Kaisis, Laura J. Thei, Gary J. Stephens, Mark L. Dallas
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/12/1459
_version_ 1797455815288815616
author Eleni Kaisis
Laura J. Thei
Gary J. Stephens
Mark L. Dallas
author_facet Eleni Kaisis
Laura J. Thei
Gary J. Stephens
Mark L. Dallas
author_sort Eleni Kaisis
collection DOAJ
description Cav2.2 channels are key regulators of presynaptic Ca<sup>2+</sup> influx and their dysfunction and/or aberrant regulation has been implicated in many disease states; however, the nature of their involvement in Alzheimer’s disease (AD) is less clear. In this short communication, we show that recombinant hCav2.2/b<sub>1b</sub>/a<sub>2</sub>d<sub>1</sub> channels are modulated by human synthetic AD-related protofibrillar amyloid beta Ab<sub>1-42</sub> peptides. Structural studies revealed a time-dependent increase in protofibril length, with the majority of protofibrils less than 100 nm at 24 h, while at 48 h, the majority were longer than 100 nm. Cav2.2 modulation by Ab<sub>1-42</sub> was different between a ‘low’ (100 nM) and ‘high’ (1 µM) concentration in terms of distinct effects on individual biophysical parameters. A concentration of 100 nM Ab<sub>1-42</sub> caused no significant changes in the measured biophysical properties of Cav2.2 currents. In contrast, 1 µM Ab<sub>1-42</sub> caused an inhibitory decrease in the current density (pA/pF) and maximum conductance (Gmax), and a depolarizing shift in the slope factor (k). These data highlight a differential modulation of Cav2.2 channels by the Ab<sub>1-42</sub> peptide. Discrete changes in the presynaptic Ca<sup>2+</sup> flux have been reported to occur at an early stage of AD; therefore, this study reveals a potential mechanistic link between amyloid accumulation and Ca<sub>v</sub>2.2 channel modulation.
first_indexed 2024-03-09T15:59:29Z
format Article
id doaj.art-8fc899a6a6a04957b360d09f7ba072aa
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T15:59:29Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-8fc899a6a6a04957b360d09f7ba072aa2023-11-24T17:15:32ZengMDPI AGPharmaceuticals1424-82472022-11-011512145910.3390/ph15121459Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated ChannelsEleni Kaisis0Laura J. Thei1Gary J. Stephens2Mark L. Dallas3School of Pharmacy, University of Reading, Reading RG6 6UB, UKSchool of Pharmacy, University of Reading, Reading RG6 6UB, UKSchool of Pharmacy, University of Reading, Reading RG6 6UB, UKSchool of Pharmacy, University of Reading, Reading RG6 6UB, UKCav2.2 channels are key regulators of presynaptic Ca<sup>2+</sup> influx and their dysfunction and/or aberrant regulation has been implicated in many disease states; however, the nature of their involvement in Alzheimer’s disease (AD) is less clear. In this short communication, we show that recombinant hCav2.2/b<sub>1b</sub>/a<sub>2</sub>d<sub>1</sub> channels are modulated by human synthetic AD-related protofibrillar amyloid beta Ab<sub>1-42</sub> peptides. Structural studies revealed a time-dependent increase in protofibril length, with the majority of protofibrils less than 100 nm at 24 h, while at 48 h, the majority were longer than 100 nm. Cav2.2 modulation by Ab<sub>1-42</sub> was different between a ‘low’ (100 nM) and ‘high’ (1 µM) concentration in terms of distinct effects on individual biophysical parameters. A concentration of 100 nM Ab<sub>1-42</sub> caused no significant changes in the measured biophysical properties of Cav2.2 currents. In contrast, 1 µM Ab<sub>1-42</sub> caused an inhibitory decrease in the current density (pA/pF) and maximum conductance (Gmax), and a depolarizing shift in the slope factor (k). These data highlight a differential modulation of Cav2.2 channels by the Ab<sub>1-42</sub> peptide. Discrete changes in the presynaptic Ca<sup>2+</sup> flux have been reported to occur at an early stage of AD; therefore, this study reveals a potential mechanistic link between amyloid accumulation and Ca<sub>v</sub>2.2 channel modulation.https://www.mdpi.com/1424-8247/15/12/1459ion channelamyloid betavoltage-gated calcium channelneurodegenerationAlzheimer’s disease
spellingShingle Eleni Kaisis
Laura J. Thei
Gary J. Stephens
Mark L. Dallas
Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
Pharmaceuticals
ion channel
amyloid beta
voltage-gated calcium channel
neurodegeneration
Alzheimer’s disease
title Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
title_full Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
title_fullStr Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
title_full_unstemmed Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
title_short Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
title_sort protofibrillar amyloid beta modulation of recombinant hcav2 2 n type voltage gated channels
topic ion channel
amyloid beta
voltage-gated calcium channel
neurodegeneration
Alzheimer’s disease
url https://www.mdpi.com/1424-8247/15/12/1459
work_keys_str_mv AT elenikaisis protofibrillaramyloidbetamodulationofrecombinanthcav22ntypevoltagegatedchannels
AT laurajthei protofibrillaramyloidbetamodulationofrecombinanthcav22ntypevoltagegatedchannels
AT garyjstephens protofibrillaramyloidbetamodulationofrecombinanthcav22ntypevoltagegatedchannels
AT markldallas protofibrillaramyloidbetamodulationofrecombinanthcav22ntypevoltagegatedchannels